Clinical Trials on Virus Diseases in United Kingdom

Total 147316 results

PepTcell Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model

Influenza

United Kingdom
GlaxoSmithKline
University of Surrey

Completed

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England

Influenza, Human

United Kingdom
Crucell Holland BV
Retroscreen Virology Ltd.

Completed

Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge

Influenza

United Kingdom
GlaxoSmithKline
University of Surrey

Completed

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines

Influenza, Human

United Kingdom
Biota Scientific Management Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

CS-8958 Single Inhaled Dose in Elderly

Influenza

United Kingdom
Public Health England
Royal Free and University College Medical School

Completed

Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status (CMVflu)

Influenza

United Kingdom
Biota Scientific Management Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958

Influenza

United Kingdom
Autoimmune Technologies, LLC
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain

Influenza

United Kingdom
Novartis
Novartis Vaccines

Withdrawn

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Influenza

United Kingdom
Novartis Vaccines

Completed

Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008

Influenza

United Kingdom
Hvivo

Completed

Influenza Challenge Study in Healthy Volunteers

Influenza

United Kingdom
University of Oxford

Completed

A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1

Influenza

United Kingdom
University of Oxford

Completed

A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine

Influenza

United Kingdom
Theraclone Sciences, Inc.

Unknown

Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza

Influenza

United Kingdom
University Hospitals, Leicester
Public Health England; Novartis Vaccines

Completed

Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults

Influenza

United Kingdom
Immune Targeting Systems Ltd
Hammersmith Medicines Research

Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine

Influenza

United Kingdom
University of Reading

Unknown

PRIMAGE (Probiotics, Immunity and Ageing) (PRIMAGE)

Influenza

United Kingdom
NHS Blood and Transplant
Irish Blood Transfusion Service; Welsh Blood Service; Scottish National Blood...

Completed

Notification of Donors With Positive Microbiology Markers

Hepatitis B | Hepatitis C | Human Immunodeficiency Virus | Creutzfeldt-Jakob Syndrome | Human T-lymphotropic Virus I & II

United Kingdom
AiCuris Anti-infective Cures AG

Completed

Thorough QT/QTc of Pritelivir in Healthy Subjects

HSV Infection

United Kingdom
University of Oxford

Completed

A Study of a New Vaccine Against Two Types of Ebola

Ebola

United Kingdom
Imperial College London

Completed

The Boceprevir and Sildenafil Pharmacokinetics Study

Hepatitis C

United Kingdom
St Stephens Aids Trust
University of Turin, Italy; University of Liverpool

Completed

Boceprevir and Ucalm (St John&Apos;s Wort)

Hepatitis C

United Kingdom
Imperial College London

Completed

Characterisation of Human B Cell Maturation in Response to Vaccination (BVAC)

Hepatitis B

United Kingdom
Imperial College London
Royal Free Hospital NHS Foundation Trust; Hvivo

Completed

SARS-CoV-2 Human Challenge Characterisation Study

COVID-19 | Covid19 | Corona Virus Infection | SARS-CoV Infection | Coronavirus

United Kingdom
University College, London

Completed

Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

Viraemia

United Kingdom
Gilead Sciences

Completed

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

HIV Infections

United Kingdom
University of Oxford

Terminated

Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)

MERS (Middle East Respiratory Syndrome)

United Kingdom
Barts & The London NHS Trust
National Health Service, United Kingdom

Completed

Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu) (ViDiFlu)

Respiratory Tract Infections | Influenza

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy

HIV Infections

United Kingdom
Mid and South Essex NHS Foundation Trust
Foundation for Liver Research

Recruiting

Immune Response in Patients With Hepatitis B and C Infection

Hepatitis B | Hepatitis C

United Kingdom
Pulmatrix Inc.
Quintiles, Inc.; Retroscreen Virology Ltd.

Completed

Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects

Healthy

United Kingdom
University of Nottingham
University of Maryland; Imperial College London; University College, London; Wake... and other collaborators

Completed

Evaluating Modes of Influenza Transmission (EMIT)

Influenza, Human

United Kingdom
Imperial College Healthcare NHS Trust
Pulmocide Ltd

Completed

Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis (RSV-SAM)

Respiratory Failure | Bronchiolitis | RSV Infection | Bronchiolitis, Viral

United Kingdom
Pfizer

Completed

A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body

Human Immunodeficiency Virus (HIV)

United Kingdom
Hvivo
Pfizer

Recruiting

Dose, Safety, and Pathogenicity of a New Influenza B Strain

Influenza B

United Kingdom
Imperial College London
Public Health England

Completed

Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children (FluSHED-2)

Influenza Vaccines

United Kingdom
Celltrion

Completed

A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model

Influenza A

United Kingdom
University of Warwick
University Hospital Birmingham

Completed

An Improvement Project Around Staffs' Influenza Vaccine Uptake

Influenza Vaccination

United Kingdom
Duke University
United States Department of Defense; Imperial College of London

Unknown

Biomarkers Predicting Infectivity in an Experimental Human Influenza Model (PRESAGE)

Influenza A

United Kingdom
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects

Influenza | Seasonal Influenza

United Kingdom
Immune Targeting Systems Ltd

Completed

Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge

Influenza A

United Kingdom
Valneva Austria GmbH
National Institute for Health Research, United Kingdom

Completed

Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

SARS-CoV-2 Virus Infection

United Kingdom
PENTA Foundation

Completed

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children (PENTA 13)

HIV Infection

United Kingdom
University of Nottingham
Northumbria University

Completed

Mood and Influenza Vaccine Response: A Feasibility Trial

Vaccination; Infection

United Kingdom
PowderMed

Completed

Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu

Influenza (Pandemic)

United Kingdom
Cocrystal Pharma, Inc.
hVIVO Services Limited

Recruiting

Influenza Viral Challenge Study of CC-42344 in Healthy Participants

Influenza A

United Kingdom
ENA Respiratory Pty Ltd

Completed

INNA-051 Influenza Challenge Study

Influenza Prophylaxis

United Kingdom
University of Warwick

Completed

Influenza 2020/2021

Influenza Vaccine

United Kingdom
University of Aberdeen
NHS Grampian

Completed

Factors Associated With Late HIV Diagnosis in Grampian: an Epidemiological Study

Human Immunodeficiency Virus

United Kingdom
Hvivo
Prep Biopharm Limited

Completed

Study Examining PrEP-001 in Healthy Subjects

Influenza A H3N2

United Kingdom

Clinical Trials on Virus Diseases in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations